June 2, 2008 - Abbott has submitted an application for Seizo Hanbai Shonin (Marketing Authorization License) to Japan's ...
Abbott's StarClose SE Vascular Closure System, a next-generation vessel closure device, is engineered to enable fast and ...
May 20, 2008 – Abbott launched the StarClose SE Vascular Closure System, a next-generation vessel closure device ...
Abbott Vascular’s HI-TORQUE WHISPER guidewire is designed to offer a higher level of support to facilitate device ...
March 13, 2008 – Abbott’s fully bioabsorbable drug-eluting stent for the treatment of coronary artery disease ...
March 11, 2008 - Abbott announced today that it has received CE Mark (Conformite Europeene) approval for a 2.25 mm ...
February 18, 2008 - Abbott received FDA approval for SIMCOR a fixed-dose combination of two cholesterol therapies ...
February 1, 2008 - Abbott has received reimbursement approval in France for its XIENCE V Everolimus Eluting Coronary ...
December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...
December 4, 2007 - Patients treated with Abbott Laboratories Inc.’s experimental drug-coated heart stent had low rates ...